合肥天麦生物科技发展有限公司/Hefei Tianmai Biotechnology Development Revenue
Pharmaceutical Manufacturing • 
Shushan District, Anhui, China • 51-100 Employees
合肥天麦生物科技发展有限公司/Hefei Tianmai Biotechnology Development revenue & valuation
| Annual revenue | $7,500,000 |
| Revenue per employee | $142,000 |
| Estimated valuation?This valuation is estimated based on industry average for the Pharmaceutical Manufacturing industry and current estimated revenues | $24,000,000 |
| Total funding | No funding |
Key Contact at 合肥天麦生物科技发展有限公司/Hefei Tianmai Biotechnology Development
Zelig Yehuda
Chief Technology Officer
Company overview
| Headquarters | Shushan District, Anhui, China |
| Phone number | +862023033011 |
| Website | |
| NAICS | 3254 |
| SIC | 283 |
| Founded | 2007 |
| Employees | 51-100 |
合肥天麦生物科技发展有限公司/Hefei Tianmai Biotechnology Development Email Formats
合肥天麦生物科技发展有限公司/Hefei Tianmai Biotechnology Development uses 5 email formats. The most common is {first name}.{last name}@company.com (e.g., john.doe@company.com), used 48.2% of the time.
| Format | Example | Percentage |
|---|---|---|
{first name}.{last name}@company.com | john.doe@company.com | 48.2% |
{first name initial}{last name}@company.com | {first name initial}doe@company.com | 24.1% |
{first name}@company.com | john@company.com | 12.4% |
{last name}.{first name}@company.com | doe.john@company.com | 8.9% |
{first name}{last name}@company.com | johndoe@company.com | 6.4% |
About 合肥天麦生物科技发展有限公司/Hefei Tianmai Biotechnology Development
Ⅰ.Company 1.Registration information (1).Established in October 2007 (2).Share capital 752.9 million (May,2016) (3).RMB 1.5b ($230m) invested, RMB 450m ($70m) needed for phase II (4).Engaged in developing and manufacturing of biopharmaceuticals (5).With insulin as the first product to enter the industry, followed with insulin analogs (6).Target at international market as well as Chinese market 2.Mission (1).Promotion to national biopharmaceutical industry (2).Provision of quality products and services to the society (3).Platform for success of all the people devoted to the career 3.Vision (1).A company worthy of trust and respect (2).One of the leading biopharmaceutical companies in Asia 4.Quality Policy (1).Quality first, continual improvement (2).Management by science, efforts for perfection Ⅱ.Products 1.Insulin(TM-101 (1).Regular (2).NPH (3).Pre-mixed (30/70) (4).Pre-mixed (50/50) 2.Analogs (1).TM －103 (NME) (2).TM －104 (Glargine) (3).TM －105 (Lispro) (4).TM －106 (Aspart) Ⅲ..Insulin Process 1.API:WCB(E.coli)→Fermentation→Inclusion body→Refolding→Purification→Crystallization→Vacuum Drying 2.FDF:Insulin API→Formulation→Filling→Packaging Ⅳ.Quality Management – QMS Activities 1.Risk Management: RA for key equipments,materials, and process 2.Deviation Management 3.Quality Investigation 4.CAPA 5.Change Control 6.Quality Review / Trending 7.Self Inspection 8.Training: Orientation, SMP/SOP, operation
Employees by Management Level
Total employees: 51-100
Seniority
Employees
Employees by Department
合肥天麦生物科技发展有限公司/Hefei Tianmai Biotechnology Development has 2 employees across 2 departments.
Departments
Number of employees
Funding Data
合肥天麦生物科技发展有限公司/Hefei Tianmai Biotechnology Development has never raised funding before.
合肥天麦生物科技发展有限公司/Hefei Tianmai Biotechnology Development Tech Stack
Discover the technologies and tools that power 合肥天麦生物科技发展有限公司/Hefei Tianmai Biotechnology Development's digital infrastructure, from frameworks to analytics platforms.
UI frameworks
JavaScript libraries
United Arab Emirates
United States
United Kingdom
Kenya
Italy
Frequently asked questions
4.8
40,000 users
